Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Forkhead box F1 (FOXF1)-regulated DNA elements are specific genomic sequences, including enhancers and promoters, that serve as binding sites for the FOXF1 transcription factor or control the expression of the FOXF1 gene itself. These elements are essential for the transcriptional regulation of genes involved in pulmonary vasculogenesis, lung septation, and mesenchymal cell proliferation (UniProt Q12946). In humans, the proper functioning of these DNA elements is critical during embryonic development, particularly for the formation of the alveolar capillary network. Deletions or point mutations in the 60 kb genomic region located approximately 250 kb upstream of the FOXF1 gene—which acts as a lung-specific enhancer—are a major cause of Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins (ACDMPV) (PubMed 23603761). Beyond developmental disorders, FOXF1-regulated elements are implicated in the pathogenesis of various cancers, where they may be hijacked to promote epithelial-mesenchymal transition and metastasis (PubMed 27161204). While there are currently no approved small-molecule drugs that directly target these DNA elements, they are primary candidates for emerging genetic therapies, including CRISPR-mediated activation or repression and antisense oligonucleotide interventions. The therapeutic challenge lies in achieving tissue-specific modulation to avoid systemic developmental toxicity or oncogenic risks associated with misregulation of the FOXF1 pathway.
Transcription factor binding to cis-regulatory elements to recruit transcriptional co-activators and RNA polymerase II, thereby modulating the expression of genes essential for pulmonary and vascular development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forkhead box F1-regulated DNA elements (FOXF1-REs).